Skip to search formSkip to main contentSkip to account menu

HMR 3647

Known as: HMR-3647, HMR3647 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND Malaria is on the increase due to emergence of parasite drug resistance and there is thus an urgent need for the… 
Review
2001
Review
2001
Recent semi-synthetic studies of erythromycin A culminated in the discovery of two ketolide drug candidates, HMR-3647 and ABT-773… 
2001
2001
ABSTRACT The in vivo activity of telithromycin against erythromycin A- and penicillin G-resistant Streptococcus pneumoniae was… 
Review
2001
Review
2001
The ketolide telithromycin (HMR-3647; Ketek), a derivative of clarithromycin, has been launched by Aventis Pharma (formerly… 
2001
2001
Six structurally related 3-keto-substituted macrolide antibiotics (ketolides) were compared for concentration-dependent… 
2001
2001
The inhibitory and bactericidal effects of telithromycin (HMR 3647, RU 66647) were compared with those of gentamicin, ampicillin… 
1998
1998
ABSTRACT Ninety-four erythromycin-susceptible and 107 erythromycin-resistant enterococcal strains (MIC of ≥512 μg/ml) were…